EUVIMEDScopri EUVIMED
Crossref

The Combined Therapy of Teriparatide and Raloxifene Improves Osseointegration of Dental Implants in the Osteoporotic Rabbit Model

Ahmet Emin Demirbaş, Firas Mohsen, Cihan Topan, Mustafa Karakaya, Nükhet Kütük, Alper Alkan

The International Journal of Oral & Maxillofacial Implants · 2024

DOI: 10.11607/jomi.10040 ↗

At a glance

Journal article in The International Journal of Oral & Maxillofacial Implants, 2024. Written by Ahmet Emin Demirbaş and 5 co-authors. Major MEDLINE topics: Teriparatide, Raloxifene Hydrochloride, Osseointegration, Dental Implants.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

PURPOSE: To evaluate the efficacy of combined therapy of teriparatide and raloxifene on the osseointegration of titanium dental implants in a rabbit model of osteoporotic bone. MATERIALS AND METHODS: Sixty female rabbits were randomly divided into six groups. The sham ovariectomy group (control) consisted of animals that received no medication. Animals in the ovariectomy group (OVX) underwent ovariectomy and received no medication. The combined group consisted of ovariectomized animals that received combined teriparatide (10 mg/kg) for 12 weeks and raloxifene (10 mg/kg) for 12 weeks. The sequential group (SEQ) consisted of ovariectomized animals that received teriparatide (10 mg/kg) for the first 6 weeks and raloxifene therapy (10 mg/kg) for the following 6 weeks sequentially. The parathormone (PTH) and raloxifene (RAL) groups consisted of ovariectomized animals that received only teriparatide (10 mg/kg) for 12 weeks or raloxifene (10 mg/kg) for 12 weeks, respectively. Dental implants (Bilimplant) were placed in the proximal metaphysis of both tibias in all rabbits. Histomorphometric and microCT studies were performed on the specimens obtained from the right tibia bone. Removal torque (RTQ) and implant stability quotient (ISQ) tests were performed on the specimens obtained from the left tibia bone. The results were compared and evaluated statistically. RESULTS: RTQ analysis revealed a statistically significant difference between the mean values of the combined group (93.01 ± 27.19 Ncm) and the OVX group (49.6 ± 12.5 Ncm) (P = .015). The highest mean T0 (implantation day) value was obtained in the control group (67.1 ± 3.4 Ncm), and the lowest mean value was obtained in the OVX group (61.4 ± 3.8 Ncm). The highest T1 mean (3 months after implantation) was obtained by the combined group (76.6 ± 3.8 Ncm), and the lowest mean was obtained by the OVX group (68.9 ± 6.2 Ncm). Histomorphometric analyses showed that the mean percentage of bone-to-implant contact (BIC%) of the combined group (51.2%) was significantly higher than that of the OVX group (28.6%) (P =.006). In the microCT examinations, it was found that the mean BIC% value of the combined group (41.1%) was significantly higher than that of the OVX group (24.1%) (P < .001). CONCLUSIONS: According to the results of the current study, combined therapy of teriparatide and raloxifene improves the BIC and osseointegration of titanium dental implants in osteoporotic bone compared with sequential or independent therapy with these agents.

Subjects

MeSH terms (MEDLINE)

TeriparatideRaloxifene HydrochlorideOsseointegrationDental ImplantsBone Density Conservation AgentsDisease Models, AnimalOvariectomyOsteoporosisAnimalsRabbitsFemaleDental Implantation, EndosseousX-Ray MicrotomographyRandom AllocationTitaniumDrug Therapy, Combination

Author keywords

dental implantsosseointegrationosteoporosisraloxifeneteriparatide

Substances

TeriparatideRaloxifene HydrochlorideDental ImplantsBone Density Conservation AgentsTitanium

Cite

APA

Demirbaş, A. E., Mohsen, F., Topan, C., Karakaya, M., Kütük, N., & Alkan, A. (2024). The Combined Therapy of Teriparatide and Raloxifene Improves Osseointegration of Dental Implants in the Osteoporotic Rabbit Model. The International Journal of Oral & Maxillofacial Implants. https://doi.org/10.11607/jomi.10040

Vancouver

Demirbaş AE, Mohsen F, Topan C, Karakaya M, Kütük N, Alkan A. The Combined Therapy of Teriparatide and Raloxifene Improves Osseointegration of Dental Implants in the Osteoporotic Rabbit Model. The International Journal of Oral & Maxillofacial Implants. 2024. doi:10.11607/jomi.10040

BibTeX
@article{Demirba2024,
  author = {Demirbaş, Ahmet Emin and Mohsen, Firas and Topan, Cihan and Karakaya, Mustafa and Kütük, Nükhet and Alkan, Alper},
  title = {The Combined Therapy of Teriparatide and Raloxifene Improves Osseointegration of Dental Implants in the Osteoporotic Rabbit Model},
  journal = {The International Journal of Oral & Maxillofacial Implants},
  year = {2024},
  doi = {10.11607/jomi.10040}
}
Start for free →